an increasing trendp = 0.1
Similarly, there was an increasing trend in FITC‐dextran ( p = 0.1) leakage through the MCs treated with endo/MF‐sEVs compared to the control (Figure 3B ).
Similarly, there was an increasing trend in FITC‐dextran ( p = 0.1) leakage through the MCs treated with endo/MF‐sEVs compared to the control (Figure 3B ).